Furthermore, in mice models, IL-1β signaling increases hepatic lipogenesis and steatosis by upregulating fatty acid synthase, thus highlighting the link between non-alcoholic fatty liver disease and obesity [31]. This evidence concerns the gene FASN and steatosis.